News & Updates

Show Multimedia Only

Primary aldosteronism prevalent in PTC patients with hypertension

24 Apr 2025

Papillary thyroid cancer (PTC) in individuals with arterial hypertension is independently associated with a diagnosis of primary aldosteronism (PA), reports a study.

Primary aldosteronism prevalent in PTC patients with hypertension

24 Apr 2025

Pacemaker implantation after TAVI linked to long-term poor outcomes

24 Apr 2025 by

Pacemaker implantation after transcatheter aortic valve implantation (TAVI) was associated with a significantly worse prognosis in terms of all-cause and cardiovascular (CV) mortality, according to the SwissTAVI trial presented at EHRA 2025.

Pacemaker implantation after TAVI linked to long-term poor outcomes

24 Apr 2025

PWH’s acute HF study supports predischarge initiation of SGLT2i

23 Apr 2025 by

International heart failure (HF) guidelines emphasize early predischarge initiation of all components of guideline-directed medical therapy (GDMT), including sodium-glucose cotransporter 2 inhibitors (SGLT2i), in patients hospitalized for acute HF. In an interview with MIMS Doctor, Dr Guang-Ming Tan of the Division of Cardiology, Chinese University of Hong Kong, discussed positive results of his centre’s recent study that evaluated predischarge initiation of empagliflozin in patients hospitalized for acute new-onset HF regardless of left ventricular ejection fraction (LVEF).

PWH’s acute HF study supports predischarge initiation of SGLT2i

23 Apr 2025

Use of an SGLT2 inhibitor in an elderly patient with CKM syndrome and polypharmacy

23 Apr 2025 by

An 82-year-old frail Chinese male patient with multimorbidity and polypharmacy was admitted to the rehabilitation ward in November 2024 due to prior ischaemic stroke and congestive heart failure (HF) requiring treatment with oxygen and furosemide. Focused cardiac ultrasound (FoCUS) showed a left ventricular ejection fraction (LVEF) of 50 percent, with formal echocardiography being scheduled for late 2025.

Use of an SGLT2 inhibitor in an elderly patient with CKM syndrome and polypharmacy

23 Apr 2025

$Early initiation of a soluble guanylate cyclase stimulator in an elderly patient with refractory HFrEF$

Early initiation of a soluble guanylate cyclase stimulator in an elderly patient with refractory HFrEF

23 Apr 2025 by

The patient was an 80-year-old male with multiple comorbidities, including diabetes mellitus controlled with a sodium-glucose cotransporter-2 inhibitor (SGLT2i), hypertension and coronary artery disease, for which he underwent stenting in October 2023. He also had a pacemaker implanted for heart block. His left ventricular ejection fraction (LVEF) ranged between 40–50 percent. For several years, he had been managed as an outpatient for mild heart failure (HF) symptoms and maintained independence in activities of daily living (ADL).

Early initiation of a soluble guanylate cyclase stimulator in an elderly patient with refractory HFrEF

23 Apr 2025

Heparin use may prevent pre-eclampsia onset

22 Apr 2025

Thromboprophylaxis with low molecular weight heparin (LMWH) appears to protect against the onset of superimposed pre-eclampsia, independently from aspirin use, reports a recent study.

Heparin use may prevent pre-eclampsia onset

22 Apr 2025

Hybrid or catheter ablation: Which strategy is better for non-paroxysmal AF?

22 Apr 2025 by

In the final results of the CEASE-AF* trial, a hybrid ablation strategy outshines a catheter ablation approach for the treatment of individuals with non-paroxysmal atrial fibrillation (AF).

Hybrid or catheter ablation: Which strategy is better for non-paroxysmal AF?

22 Apr 2025

Study affirms bentracimab potential for ticagrelor reversal in patients requiring surgery or with bleeding

21 Apr 2025 by

The first-in-class monoclonal antibody bentracimab effectively and safely reverses the antiplatelet effects of ticagrelor in patients with an indication for urgent or emergent surgery or with major bleeding in the single-arm phase III REVERSE-IT trial.

Study affirms bentracimab potential for ticagrelor reversal in patients requiring surgery or with bleeding

21 Apr 2025

AF patients under 70 years of age face increased dementia risk

20 Apr 2025 by

Atrial fibrillation (AF) carries a heightened risk of dementia, especially for those under 70 years of age, according to a European population-based study said to be the largest to date.

AF patients under 70 years of age face increased dementia risk

20 Apr 2025

Is catheter ablation safe for treatment of ventricular arrhythmias in early phase after ACS?

20 Apr 2025 by

Catheter ablation appears to be an effective procedure for patients with ventricular arrhythmias in the early phase following acute coronary syndrome (ACS), as shown by a study presented at EHRA 2025.

Is catheter ablation safe for treatment of ventricular arrhythmias in early phase after ACS?

20 Apr 2025

News & Updates

Filter by Specialty:

Specialty:

Primary aldosteronism prevalent in PTC patients with hypertension

Primary aldosteronism prevalent in PTC patients with hypertension

Pacemaker implantation after TAVI linked to long-term poor outcomes

Pacemaker implantation after TAVI linked to long-term poor outcomes

PWH’s acute HF study supports predischarge initiation of SGLT2i

PWH’s acute HF study supports predischarge initiation of SGLT2i

Use of an SGLT2 inhibitor in an elderly patient with CKM syndrome and polypharmacy

Use of an SGLT2 inhibitor in an elderly patient with CKM syndrome and polypharmacy

Early initiation of a soluble guanylate cyclase stimulator in an elderly patient with refractory HFrEF

Early initiation of a soluble guanylate cyclase stimulator in an elderly patient with refractory HFrEF

Heparin use may prevent pre-eclampsia onset

Heparin use may prevent pre-eclampsia onset

Hybrid or catheter ablation: Which strategy is better for non-paroxysmal AF?

Hybrid or catheter ablation: Which strategy is better for non-paroxysmal AF?

Study affirms bentracimab potential for ticagrelor reversal in patients requiring surgery or with bleeding

Study affirms bentracimab potential for ticagrelor reversal in patients requiring surgery or with bleeding

AF patients under 70 years of age face increased dementia risk

AF patients under 70 years of age face increased dementia risk

Is catheter ablation safe for treatment of ventricular arrhythmias in early phase after ACS?

Is catheter ablation safe for treatment of ventricular arrhythmias in early phase after ACS?